I have 268 prostate cancer patients and have placed them into four risk groups (low, favorable intermediate, unfavorable intermediate, and high; coded as 1, 2, 3, and 4, respectively). I want to compare the biochemical failure rates of the four groups using a competing risk regression with a competing risk being death. The analysis resulted in extremely high SHR values (3027318, 3674970 and 1.19e+07). All had P>|z| = 0.000. When I looked at the number of failures in the low-risk group, there was none. All of the other groups had failures (1, 4 and 7). Is it acceptable to report such high values for SHR or is there some other way I should analysis this data.
Thanks you,
Bob Galbreath
Thanks you,
Bob Galbreath
Comment